Radiology Partners vs Pfizer

Side-by-side comparison of AI visibility scores, market position, and capabilities

Pfizer leads in AI visibility (93 vs 72)
Radiology Partners logo

Radiology Partners

LeaderHealthcare

Physician-Led Radiology Practice Management

Radiology Partners is the largest physician-led radiology practice in the US; serves 1,000+ hospital and outpatient sites in 35+ states; integrates AI-driven imaging tools; raised $700M+ in equity and debt financing;

AI VisibilityBeta
Overall Score
B72
Category Rank
#112 of 596
AI Consensus
79%
Trend
stable
Per Platform
ChatGPT
77
Perplexity
72
Gemini
70

About

Radiology Partners is the largest physician-owned and physician-led radiology practice in the United States, founded in 2012 by Rich Whitney and Scott Seidelmann and headquartered in El Segundo, California. The company partners with hospitals, health systems, outpatient imaging centers, and specialty practices to deliver comprehensive diagnostic and interventional radiology services. Unlike corporate radiology groups that are investor-owned, Radiology Partners is structured to keep radiologists in ownership and governance positions, a model the company uses to attract and retain talent in a specialty facing significant workforce shortages.

Full profile
Pfizer logo

Pfizer

LeaderHealthcare Tech

Enterprise

Global biopharma with $63.6B FY2024 revenue; $43B Seagen ADC acquisition rebuilds post-COVID pipeline; patent cliff 2026-2028 for Eliquis; activist Starboard Value pushing restructuring.

AI VisibilityBeta
Overall Score
A93
Category Rank
#1 of 596
AI Consensus
80%
Trend
stable
Per Platform
ChatGPT
94
Perplexity
89
Gemini
94

About

Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The company trades on NYSE (PFE) and reported $63.6 billion in total revenues for FY2024, normalizing from pandemic highs of $100 billion-plus in 2021-2022 driven by Comirnaty COVID-19 vaccine revenues with BioNTech and Paxlovid COVID antiviral sales. CEO Albert Bourla has led a strategic pivot to reset the company's long-term growth profile, anchored by the landmark $43 billion acquisition of Seagen in December 2023, adding a world-class antibody-drug conjugate (ADC) oncology pipeline including Padcev, Tukysa, Adcetris, and Tivdak.

Full profile

AI Visibility Head-to-Head

72
Overall Score
93
#112
Category Rank
#1
79
AI Consensus
80
stable
Trend
stable
77
ChatGPT
94
72
Perplexity
89
70
Gemini
94
76
Claude
92
78
Grok
98

Key Details

Category
Physician-Led Radiology Practice Management
Enterprise
Tier
Leader
Leader
Entity Type
brand
company

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.